Command Palette

Search for a command to run...

BAFNAPH
156.03(-2.00%)
1W: -9.66%

Bafna Pharmaceuticals Key Ratios

Cash Conversion Cycle

Latest:-366.4 days

Return on Equity

Latest:-25.4%

Return on Capital Employed

Latest:-3.0%

Dupont Analysis

Analysis Summary

MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROE-23.51%-40.67%-44.15%-67.95%-25.42%
PAT margin-58.22%-43.25%-35.48%-29.38%-16.44%
Asset Turnover0.44x0.36x0.30x0.34x0.45x
Leverage3.05x3.87x4.13x4.52x12.88x

Efficiency Ratios

Analysis Summary

MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Inventory Days68.791.1106.183.588.9
Receivable Days330.9335.0302.0205.5132.6
Payable Days231.6227.1287.4519.7587.9
Cash Conversion Cycle168.0199.1120.6-230.7-366.4

Return Ratios

Analysis Summary

MetricMar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROE-23.51%-40.67%-44.15%-67.95%-25.42%
ROCE-1.70%-6.77%-7.42%-21.59%-2.99%
ROA-7.72%-10.50%-10.68%-15.02%-1.97%

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.